- Home
- WTTR vs OCS Comparison
WTTR vs OCS Comparison
Compare WTTR & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTTR
- OCS
- Stock Information
- Founded
- WTTR 2016
- OCS 2003
- Country
- WTTR United States
- OCS Switzerland
- Employees
- WTTR N/A
- OCS N/A
- Industry
- WTTR Oilfield Services/Equipment
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- WTTR Energy
- OCS Health Care
- Exchange
- WTTR Nasdaq
- OCS Nasdaq
- Market Cap
- WTTR 922.1M
- OCS 1.0B
- IPO Year
- WTTR 2017
- OCS N/A
- Fundamental
- Price
- WTTR $8.86
- OCS $19.92
- Analyst Decision
- WTTR Strong Buy
- OCS Strong Buy
- Analyst Count
- WTTR 3
- OCS 4
- Target Price
- WTTR $14.83
- OCS $31.50
- AVG Volume (30 Days)
- WTTR 859.4K
- OCS 25.5K
- Earning Date
- WTTR 07-29-2025
- OCS 05-08-2025
- Dividend Yield
- WTTR 3.15%
- OCS N/A
- EPS Growth
- WTTR N/A
- OCS N/A
- EPS
- WTTR 0.34
- OCS N/A
- Revenue
- WTTR $1,459,911,000.00
- OCS $847,333.00
- Revenue This Year
- WTTR $2.68
- OCS $11.71
- Revenue Next Year
- WTTR $5.03
- OCS $1,508.86
- P/E Ratio
- WTTR $25.75
- OCS N/A
- Revenue Growth
- WTTR N/A
- OCS N/A
- 52 Week Low
- WTTR $7.20
- OCS $10.79
- 52 Week High
- WTTR $15.14
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- WTTR 57.55
- OCS 61.10
- Support Level
- WTTR $7.98
- OCS $19.00
- Resistance Level
- WTTR $8.41
- OCS $19.75
- Average True Range (ATR)
- WTTR 0.27
- OCS 0.69
- MACD
- WTTR 0.09
- OCS 0.10
- Stochastic Oscillator
- WTTR 92.44
- OCS 83.01
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.